Patents for C12P 21 - Preparation of peptides or proteins (112,499)
01/2001
01/11/2001CA2378116A1 Human immune response molecules
01/11/2001CA2377931A1 Novel mammalian calcium channels and related probes, cell lines and methods
01/11/2001CA2377793A1 Gene encoding cyclic lipopeptide acylase and expression of the same
01/11/2001CA2377784A1 Novel genes and their use in the modulation of obesity, diabetes and energy imbalance
01/11/2001CA2377731A1 Fusion peptides comprising a peptide ligand domain and a multimerization domain
01/11/2001CA2376513A1 An interleukin-1 receptor antagonist and uses thereof
01/11/2001CA2372935A1 Novel antifungal agents and fungicides, method for the production thereof and their use
01/10/2001EP1067142A1 Antibody against cleavage product of vimentin
01/10/2001EP1066393A1 Expression system for producing proteins
01/10/2001EP1066380A2 Soluble t cell receptor
01/10/2001EP1066372A1 Novel recombinant baculovirus, construction method thereof and insect pesticidal composition containing the same
01/10/2001EP1066328A1 Chimeric protein containing an intramolecular chaperone-like sequence and its application to insulin production
01/10/2001EP1066324A1 Novel mammalian g-protein coupled receptors having extracellular leucine rich repeat regions
01/10/2001EP1066322A1 Circularly permuted biotin binding proteins
01/10/2001EP1066319A1 Production methods and uses of a retrovirus
01/10/2001EP1066311A1 Compositions and methods for the identification of lung tumor cells
01/10/2001EP1066059A1 Formulations for protection of peg-interferon alpha conjugates
01/10/2001EP1066051A1 Sciellin and uses thereof
01/10/2001EP1066028A2 Methods and devices for modulating the immune response
01/10/2001EP0764209B1 Albumin expression in yeast
01/10/2001CN1279718A Fusion proteins comprising HIV-1 Tat and/or Nef proteins
01/10/2001CN1279712A Lactobacillus helveticus bacterium having high capability of producing tripentide, fermented milk product, and preparing process thereof
01/10/2001CN1279692A Anti-idiotype monoclonal antibodise, their use in active immunotherapy of malignant tumors and compositions containing them
01/10/2001CN1279690A Soluble single-chain T-cell receptor proteins
01/10/2001CN1279689A Vitamin D receptor related polypeptides, nucleic acid sequence encoding the same and uses thereof
01/10/2001CN1279290A Human signal recognition particle receptor beta and its coding sequence, preparing process and application
01/10/2001CN1279289A Human P47 protein and its coding sequence
01/09/2001US6172279 Plant gene construct encoding a protein capable of disrupting the biogenesis of viable pollen
01/09/2001US6172213 Anti-IgE antibodies and method of improving polypeptides
01/09/2001US6172211 Nucleotide sequences which codes a protein that modulates tumor propagation; for the treatment of cancer; antitumor agents; anticarcinogenic agents; antiproliferative agents
01/09/2001US6172201 Cellular receptor for HIV-1 Vpr essential for G2/M phase
01/09/2001US6172200 Monoclonal antibody that preferentially binds protein; for use as diagnostic tool in analyzing embryonic development and cellular regulation; for the detection of modulators of gene expression
01/09/2001US6172198 Monoclonal antibody which binds to pregnancy associated plasma protein; for the detection of pereferential cancers and down's syndrome pregnancies
01/09/2001US6172194 ARF-p19, a novel regulator of the mammalian cell cycle
01/09/2001US6172193 Escape mutant of the surface antigen of hepatitis B virus
01/09/2001US6172192 Polypeptide or peptide associated microorganism infection; for diagnosis and prevention protozoan infection of mammals
01/09/2001US6172188 Fluorescent proteins
01/09/2001US6172048 Composition containing nucleic acids, preparation and uses
01/09/2001US6172042 Synthetic peptides that inhibit IL-6 activity
01/09/2001US6171859 Defective cytochrome c oxidase; diagnosing alzheimer*s disease
01/09/2001US6171855 Adenoviral expression cassettes which express heterologous gene products; for gene therapy
01/09/2001US6171846 Culturing cells which are blocked in the synthesis of virginimycins; mutating genes in target microorganism and recovering cells with mutated target genes
01/09/2001US6171838 ratB
01/09/2001US6171829 Has inhibitory activity to kainic acid toxicity; treatment and prevention of nervous system disorders; from culture of eupenicillium
01/09/2001US6171825 Culturing mammalian host cells in medium supplemented with copper ions and free of plasma-derived protein and polyol supplements
01/09/2001US6171820 Saturation mutagenesis in directed evolution
01/09/2001US6171819 Acyl transfer with stabilized transition complex using catalyst with catalytic imidazole (e.g. histidine) function
01/09/2001US6171818 Amino acid sequence of polypeptide from aplysia punctata, a sea snail; for recombinant production of anticarcinogenic agents
01/09/2001US6171815 Human sulfonylurea receptor
01/09/2001US6171813 Enzyme catalysis in organic solutions containing water
01/09/2001US6171806 Isolated peptide defined by SEQ ID NO: 17 and uses thereof
01/09/2001US6171803 Drug screening for allergy treatments by engineering expression of alpha, beta, and gamma subunits of receptor in host cell, incubating with candidate inhibitor, and analyzing for cell expression or cell activation
01/09/2001US6171799 Immunoassay detection of a v beta 5.3 t cell by contacting tissue sample with a monoclonal antibody which reacts to variable region of beta chain of the receptor; diagnosis and treatment of rheumatoid arthritis
01/09/2001US6171792 Detection systems for registering protein interactions and functional relationships
01/09/2001US6171790 Human protease associated proteins
01/09/2001US6171787 Detecting polynucleotide of tumor necrosis factor-gamma in sample by contacting with polynucleotide of defined nucleotide sequence and determining binding/hybridization; diagnosis of inflammation and related disorders
01/09/2001US6171781 NF-AT polypeptides and polynucleotides
01/09/2001US6171598 GTP cyclohydrolase II (RIBA)
01/09/2001US6171591 Recombinant nodavirus compositions and methods
01/09/2001US6171586 Antibody formulation
01/09/2001CA2204640C Conjugates of bdnf and nt-3 with a water-soluble polymer
01/09/2001CA2192079C Human monoclonal antibodies specific to cell cycle independent glioma surface antigen
01/08/2001CA2274880A1 Icam-6 materials and methods
01/04/2001WO2001000874A2 Cancer associated antigens and uses therefor
01/04/2001WO2001000851A1 Cyclic amp phosphodiesterase isoforms and methods of use
01/04/2001WO2001000849A1 Tankyrase2 materials and methods
01/04/2001WO2001000844A2 Corynebacterium glutamicum genes encoding proteins involved in carbon metabolism and energy production
01/04/2001WO2001000843A2 Corynebacterium glutamicum genes encoding metabolic pathway proteins
01/04/2001WO2001000842A2 Corynebacterium glutamicum genes encoding proteins involved in homeostasis and adaptation
01/04/2001WO2001000839A1 Tetanus toxin polypeptides
01/04/2001WO2001000837A1 Basb111 polypeptide and polynucleotide from moraxella catharrhalis
01/04/2001WO2001000832A1 Methods for making apo-2 ligand using divalent metal ions
01/04/2001WO2001000831A1 Helical polypeptide zalpha29
01/04/2001WO2001000829A2 Human endogenous retrovirus in breast cancer
01/04/2001WO2001000828A2 Compositions and methods for the therapy and diagnosis of lung cancer
01/04/2001WO2001000822A2 Cdna sequences of two interacting fancip2 and fancip3 of the fanconi anemia complementation group a protein
01/04/2001WO2001000805A2 Corynebacterium glutamicum genes encoding proteins involved in membrane synthesis and membrane transport
01/04/2001WO2001000804A2 Corynebacterium glutamicum genes encoding stress, resistance and tolerance proteins
01/04/2001WO2001000790A1 Production of the lipidated form of the peptidoglycan-associated lipoproteins of gram-negative bacteria
01/04/2001WO2001000787A2 Methods of treatment using lig 72a and variants thereof
01/04/2001WO2001000668A1 Extraction of integral membrane proteins
01/04/2001WO2001000666A2 Self-aligning peptides derived from human elastin and other fibrous proteins
01/04/2001WO2001000648A1 Stabilized viral envelope proteins and uses thereof
01/04/2001WO2001000237A1 Synthetic peptide immunogens and antibodies thereto
01/04/2001WO2000063237A3 Pseudomycin analogs
01/04/2001WO2000060082A3 Vesicle associated proteins
01/04/2001WO2000056405A3 Human tumor necrosis factor receptor-like 2
01/04/2001WO2000050586A3 In vitro translation system
01/04/2001WO2000039302A3 Improved expression of hiv polypeptides and production of virus-like particles
01/04/2001WO2000029438A9 Egf-like nucleic acids and polypeptides and uses thereof
01/04/2001CA2594262A1 Corynebacterium glutamicum genes encoding proteins involved in carbon metabolism and energy production
01/04/2001CA2594201A1 Corynebacterium glutamicum genes encoding proteins involved in carbon metabolism and energy production
01/04/2001CA2593287A1 Corynebacterium glutamicum genes encoding proteins involved in carbon metabolism and energy production
01/04/2001CA2592965A1 Corynebacterium glutamicum genes encoding metabolic pathway proteins
01/04/2001CA2590662A1 Corynebacterium glutamicum genes encoding metabolic pathway proteins
01/04/2001CA2587112A1 Corynebacterium glutamicum genes encoding stress, resistance and tolerance proteins
01/04/2001CA2585907A1 Corynebacterium glutamicum genes encoding proteins involved in homeostasis and adaptation
01/04/2001CA2584021A1 Corynebacterium glutamicum genes encoding proteins involved in carbon metabolism and energy production
01/04/2001CA2583703A1 Corynebacterium glutamicum genes encoding proteins involved in membrane synthesis and membrane transport
01/04/2001CA2563004A1 Corynebacterium glutamicum genes encoding proteins involved in carbon metabolism and energy production